EFFECT OF BISPHOSPHONATE THERAPY ON SERUM OSTEOPROTEGERIN LEVELS IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS

被引：0
|
作者：
Kang, Moo-Il [1 ]
Kim, Ghi-Su [2 ]
Lim, Seung-Kil [3 ]
Baek, Ki-Hyun [1 ]
Tae, Hyun-Jung [1 ]
Lee, Kwang-Woo [1 ]
机构：
[1] Catholic Univ Korea, Coll Med, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
CALCIFIED TISSUE INTERNATIONAL | 2004年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：S85 / S86
页数：2
相关论文
共 50 条
  • [1] Effect of risedronate therapy on serum osteoprotegerin levels in patients with postmenopausal osteoporosis.
    Baek, KH
    Tae, HJ
    Han, JH
    Kang, MI
    Lee, WY
    Oh, KW
    Lee, KW
    Cho, CS
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S309 - S309
  • [2] The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis
    Karadag-Saygi, Evrim
    Akyuz, Gulseren
    Bizargity, Peyman
    Ay, Pinar
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (12) : 1033 - 1036
  • [3] EFFECT OF RALOXIFENE ON SERUM LEVELS OF OSTEOPROTEGERIN IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: 3 MONTHS RESULTS
    Munoz-Torres, M.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S81 - S81
  • [4] BISPHOSPHONATE THERAPY FOR POSTMENOPAUSAL OSTEOPOROSIS
    WATTS, NB
    SOUTHERN MEDICAL JOURNAL, 1992, 85 (08) : 2S31 - 2S33
  • [5] The Association of Serum Osteoprotegerin and Osteoporosis in Postmenopausal Hemodialysis Patients: A Pilot Study
    Wu, Wen-Tien
    Lee, Ru-Ping
    Wang, Chih-Hsien
    Fang, Te-Chao
    Lin, Nien-Tsung
    Chen, Ing-Ho
    Hsu, Bang-Gee
    JOURNAL OF WOMENS HEALTH, 2010, 19 (04) : 785 - 790
  • [6] SERUM OSTEOCALCIN LEVELS IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS
    YASUMURA, S
    ALOIA, JF
    VASWANI, AN
    YEH, JK
    LOMONTE, AF
    YUEN, K
    COHN, SH
    JOURNAL OF BONE AND MINERAL RESEARCH, 1986, 1 (01) : 121 - 121
  • [7] SERUM MAGNESIUM LEVELS IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS
    Georgescu, L. M.
    Straciuc, O.
    Luengo Perez, L. M.
    Pascalau, N. A.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S476 - S477
  • [8] Effects of alendronate treatment on serum levels of osteoprotegerin and total RANKL in women with postmenopausal osteoporosis
    Reyes-García, R
    Fernández-García, D
    Mezquita-Raya, P
    De la Higuera, M
    Alonso, G
    Ruiz-Requena, ME
    Escobar-Jiménez, F
    Muñoz-Torres, M
    BONE, 2005, 36 : S410 - S411
  • [9] ADHERENCE TO BISPHOSPHONATE THERAPY FOR POSTMENOPAUSAL OSTEOPOROSIS IN BULGARIA
    Kuzmanova, S. I.
    Solakov, P. T.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 374 - 374
  • [10] Persistence with bisphosphonate therapy and the impact of dosing frequency in patients with postmenopausal osteoporosis
    Penning-van Beest, FJA
    Goettsch, WG
    Erkens, JA
    Herings, RMC
    VALUE IN HEALTH, 2004, 7 (06) : 724 - 724
12345